Associate Director, Global Marketing - Obesity

MSD•North Wales, PA
•$142,400 - $224,100•Hybrid

About The Position

The Associate Director, Global Marketing – Obesity will advance global commercial strategy across obesity assets in development. The role operates at the intersection of strategy, asset development, and customer insight, with a dual focus on healthcare professional (HCP) and healthcare customer (HCC) audiences. It helps define how assets can be positioned, differentiated, and valued in future markets, building a commercial foundation that supports development decisions, future launch readiness, and value creation for patients, customers, and the enterprise. The role works across global and regional partners and contributes to strategic deliverables, governance materials, leadership updates, and cross-functional decisions. The Associate Director is expected to lead without authority and foster collaboration, strategic rigor, accountability, inclusion, and One Team ways of working.

Requirements

  • Bachelor's degree.
  • At least 7 years of progressive or combined experience in marketing, market access, strategy, or related pharmaceutical/biotechnology roles, with experience contributing to asset, brand, or portfolio strategy.
  • Experience in obesity, cardiometabolic, diabetes, cardiovascular, renal, or another highly competitive specialty market.
  • Experience developing HCP and/or HCC strategies, value propositions, positioning, messaging, or customer-insight-driven strategic deliverables.
  • Strong understanding of early asset development, commercial input into development decisions, and marketing's role in shaping target product profiles, evidence, positioning, and future launch strategy.
  • Ability to synthesize complex market, customer, clinical, competitive, and access inputs into clear strategic implications and executive-ready recommendations.
  • Skills listed include adaptability, biopharmaceutical industry knowledge, biotechnology, brand strategy, communication strategy development, creativity, cross-functional and cross-team collaboration, customer focus, customer insights, global marketing, market access, market research, product management, strategic market analysis, and strategic thinking.

Nice To Haves

  • Advanced degree, preferably an MBA.
  • Experience applying brand/marketing strategy (L3) or launch excellence frameworks to guide asset or brand strategy development.
  • Ability to anticipate how customer expectations, competitor activity, clinical evidence, access dynamics, and policy shifts may shape future opportunities.
  • Competitive intelligence experience monitoring, interpreting, and communicating insights to inform strategic choices and franchise priorities.
  • Proven strategic planning ability, including analyzing complex data, making clear strategic choices, and developing long-term customer-centric strategies.
  • Ability to create high-value deliverables from white space, operate with ambiguity, and proactively identify differentiation opportunities.
  • Strong cross-functional leadership across Commercial, Clinical Development, Medical Affairs, Market Access, Outcomes Research, Policy, Competitive Intelligence, Forecasting, regional teams, and agency partners.
  • Ability to communicate complex insights clearly and credibly, tailor messages to senior leaders and cross-functional audiences, and drive stakeholder alignment.
  • Ability to manage multiple priorities, clarify decisions, align stakeholders, and deliver high-quality strategic outputs on time.
  • Curiosity, external orientation, learning agility, and willingness to challenge the status quo to create value for customers, patients, and the enterprise.

Responsibilities

  • Lead and support development of the overall global commercial strategy for obesity assets in development, ensuring strategies are insight-driven, future-focused, and aligned with enterprise priorities.
  • Develop differentiated HCP and HCC value propositions for each asset, including customer-specific benefits, reasons to believe, and future positioning implications.
  • Apply the L3 brand strategy framework to develop and refine commercial foundations, including market in focus, asset differentiators, initial positioning, value propositions, early asset strategy, and transition-to-launch implications.
  • Partner with Clinical Development, Market Access, Outcomes Research, Manufacturing, and other cross-functional colleagues to identify commercial implications of target product profiles, endpoints, patient populations, evidence needs, and development choices.
  • Monitor, synthesize, and communicate competitive insights relevant to the obesity franchise, including emerging mechanisms, competitor development plans, market trends, customer expectations, and future scenarios.
  • Translate competitive and market insights into strategic implications for asset prioritization, differentiation, development planning, and future launch readiness.
  • Collaborate across functions to evaluate and develop identified strategic opportunities, including opportunity spaces, priority customer segments, unmet needs, access considerations, and potential innovation areas.
  • Develop strategic deliverables, governance materials, leadership updates, and decision documents that communicate commercial perspectives, assumptions, risks, opportunities, and recommended actions.
  • Partner with regional and key-market colleagues to reflect market realities and customer needs in global strategies while maintaining portfolio-wide strategic consistency.
  • Lead and collaborate as a member of the Global Commercial Team, fostering enterprise collaboration and a culture of strategic rigor, accountability, inclusion, and One Team working.

Benefits

  • Medical, dental, vision healthcare, and other insurance benefits for employees and family.
  • Retirement benefits, including 401(k).
  • Paid holidays, vacation, and compassionate and sick days.
  • Eligible for annual bonus and long-term incentive, if applicable.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service